Is Metabolic Activation of Topoisomerase II Poisons Important In The Mechanism Of Cytotoxicity?

  • Sinha B
N/ACitations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

The antitumor drugs doxorubicin and etoposide, a phodophyllotoxin derivative, are clinically active for the treatment of human malignancies. Because of their extreme effectiveness in the clinic, their modes of actions have been the subject of intense research for over several decades both in the laboratory and in the clinic. It has been found that both doxorubicin and etoposide (VP-16) act on topoisomerase II, induce DNA cleavage, and form double-strand breaks, causing tumor cell death. However, both of these drugs also undergo extensive metabolism in tumor cells and in vivo to various reactive intermediates that bind covalently to cellular DNA and proteins. Moreover, both drugs are metabolized to reactive free radicals that induce lipid peroxidation and DNA damage. However, the role of drug activation in the mechanism of cytotoxicity remains poorly defined. In this review, we critically evaluate the significance of metabolic activation of doxorubicin and etoposide in the mechanism of tumor cytotoxicity.

Cite

CITATION STYLE

APA

Sinha, B. K. (2015). Is Metabolic Activation of Topoisomerase II Poisons Important In The Mechanism Of Cytotoxicity? Journal of Drug Metabolism & Toxicology, 06(03). https://doi.org/10.4172/2157-7609.1000186

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free